, Tracking Stock Market Picks
Enter Symbol:
Incyte Corporation (INCY) [hlAlert]

up 973.04 %

Incyte Corporation (INCY) rated Outperform with price target $16 by Robert W. Baird

Posted on: Wednesday,  Apr 16, 2008  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Incyte Corporation (NASDAQ: INCY) on 04/16/2008, when the stock price was $10.61. Since
then, Incyte Corporation has gained 973.04% as of 01/14/2016's recent price of $113.85.
If you would have followed this Robert W. Baird's recommendation on INCY, you would have gained 973.04% of your investment in 2829 days.

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte?s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/16/2008 8:25 AM Buy
10.61 16.00
as of 12/24/2008
1 Week down  -3.12 %
1 Month down  -7.26 %
3 Months down  -26.19 %
1 YTD down  -42.74 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy